A falling stock does not always mean a weak business. At times, the market reacts to a scary headline before it looks at the full picture. This can create a gap between the share price and the actual health of a company.
That gap is where value investors often look for opportunities.
The idea is simple. A company may face a real problem, but the market may price in a much worse outcome than what is likely to happen. If profits stay strong, cash flow remains healthy and the business keeps its long-term edge, the lower share price can become attractive.
This does not mean every falling stock is a bargain. Some stocks fall for very good reasons. The real task is to separate a temporary problem from a lasting business decline.
Several names now show this type of setup.
Cigna: Cheap Despite Business Strength
Cigna has faced pressure from concerns about health care costs, changes to its business mix and its decision to review strategic options for eviCore.
Those headlines can make the story look less attractive. But the numbers offer another view.
In the first quarter of 2026, Cigna Healthcare revenue reached $11.5 billion. Pretax adjusted earnings from Cigna Healthcare rose 18% year over year to $1.5 billion. Its medical care ratio was 79.8%, which was better than the company’s earlier guidance. Operating cash flow stood at $1.1 billion.
The company also plans to leave the individual exchange business at the end of 2026 and has started a strategic review of eviCore. Management says these are deliberate moves that can help the company focus on its stronger core businesses.
Valuation is another reason investors may want to take a closer look. Cigna’s projected 2026 P/E ratio is about 11.3 times, based on current estimates. That falls to about 9.9 times for 2027.
The main risk is clear. Health care costs could rise, and changes to the business could create pressure on earnings. But if the core operation remains strong, the current valuation may leave room for a recovery.
Jabil: The Quiet AI Winner
Jabil does not receive the same attention as famous AI chip companies. That may be part of its appeal.
Jabil builds and manages products for major technology companies. It also has exposure to data centers, networking and other parts of the technology supply chain.
Its recent numbers have been strong. In the third quarter of fiscal 2026, Jabil posted $8.8 billion in revenue. GAAP operating income came to $445 million, while core operating income reached $504 million. Core diluted EPS was $3.16.
More important, the company raised its fiscal 2026 outlook. Management said AI infrastructure demand remained very strong and that its full-year AI-related revenue outlook was now meaningfully higher. Performance also improved in areas such as automotive and connected living.
This creates an interesting contrast. Investors may focus on economic uncertainty or weaker parts of the electronics market, while Jabil continues to benefit from major investment in data centers.
The risk is that technology spending can slow. Still, its broad customer base and exposure to infrastructure give the company a different profile from a pure AI bet.
Veeva: AI Fear May Be Overdone
Veeva Systems has faced a different kind of problem. Investors worry that artificial intelligence could reduce the value of traditional software.
That fear has hurt many software companies.
Veeva, however, has a strong position in life sciences. Its software supports areas such as research, regulation, quality and commercial work. These systems are deeply tied to the work of pharmaceutical and biotechnology companies.
In fiscal 2026, Veeva generated $3.2 billion in revenue and $1.4 billion in non-GAAP operating income. A recent investment analysis placed the stock at $169.02 and estimated fair value at $210, a 24% gap.
The market has focused on three concerns: AI displacement, Salesforce competition and lower software valuations. Yet the same analysis argues that Veeva’s core business alone can support much of its value, without any major AI revenue boost.
That is important.
If AI becomes a tool that works on top of Veeva rather than a replacement for it, the fear around the stock could prove excessive.
Adobe: A Real Risk With a Real Opportunity
Adobe may offer one of the more interesting value setups, but it also carries more risk.
Adobe has suffered from worries that cheaper AI tools could reduce demand for its traditional products. Its shares were down nearly 18% in 2026 as of the latest report, with the stock at $287.73.
There are genuine concerns. Adobe saw a faster-than-expected decline in its traditional standalone stock business. Investors also worry about customer consolidation and cheaper alternatives. Leadership changes have added another layer of uncertainty, with CEO Shantanu Narayen set to leave once a successor is chosen.
But Adobe’s AI story is not only negative.
In the first quarter of fiscal 2026, Creative and Marketing Professionals subscription revenue rose 12% year over year to $4.39 billion. Creative premium monthly active users crossed 80 million, up more than 50% year over year. Firefly ending ARR also passed $250 million.
Adobe still expects total ARR growth of 10.2% for fiscal 2026.
The stock therefore offers a simple but important debate. Is AI destroying Adobe’s business, or is it changing the products Adobe sells? The answer will decide whether today’s lower price becomes a bargain or a value trap.
Indian Auto Stocks: Strong Sales, Weak Share Prices
India’s auto sector also offers a useful example of how headlines and prices can move in different directions.
On September 2, major auto stocks came under heavy pressure even though August sales were strong across most vehicle segments. The Nifty Auto index fell 2.38% to 27,802.65 at its low, while all index stocks traded in the red at that point.
Hero MotoCorp and Mahindra & Mahindra were among the names that saw sharp falls. The wider decline came despite healthy yearly sales growth.
This does not automatically mean these stocks are cheap. Monthly sales can change, margins can move and the market may already have priced in strong demand.
Still, the reaction is worth attention. When a stock falls even as its main operating numbers remain healthy, investors should ask why.
If the answer is mainly profit-taking, market weakness or short-term concerns, the decline may create a better entry point.
Hindustan Zinc: Commodity Fear Versus Earnings Power
Hindustan Zinc offers another example.
Metal stocks recently came under pressure after weaker metal prices and concerns about higher-for-longer US interest rates. Profit booking after a strong August rally also hurt sentiment. Hindustan Zinc was among the names affected.
Yet Jefferies remains positive on the company. Its latest target price is ₹750, which suggests 25.5% upside based on the cited reference price. The brokerage expects zinc and silver prices to support earnings, with its FY27-28 zinc assumptions 9-11% below spot prices. Its silver assumptions of $60-$63 per ounce are also 5-9% below spot.
Hindustan Zinc also plans to expand refined metal capacity by 30% to about 1.5 million tonnes. Silver capacity is expected to reach 830 tonnes by the second quarter of FY29. Jefferies expects net cash to rise from ₹52 billion in FY26 to ₹227 billion by FY29.
That gives investors a stronger reason to study the stock beyond the daily movement in metal prices.
The Difference Between Cheap and Good Value
The biggest lesson from these companies is that a low price alone means very little.
Cigna has a low valuation but faces health care cost risks. Jabil has strong AI exposure but remains tied to the wider technology cycle. Veeva faces AI fears, yet its core software business remains strong. Adobe has real competitive threats but also has a large and growing AI opportunity. Auto stocks have strong sales but can still face valuation pressure. Hindustan Zinc benefits from attractive commodity prices but remains exposed to commodity cycles.
A smart buy-low strategy therefore needs more than a falling chart.
The business must remain healthy. Cash flow must support the valuation. Debt must stay under control. Most importantly, there should be a clear reason for the market to change its view.
The Bottom Line
Bad headlines can create attractive prices, but they can also hide serious problems.
The best opportunities appear when the headline looks worse than the underlying business. Cigna, Jabil, Veeva, Adobe, selected Indian auto stocks and Hindustan Zinc each show parts of this setup in different ways.
The goal is not to buy every stock after a fall. It is to find companies where the market may have gone too far in its negative view.
That is where a bad headline can become a good entry point.
ALSO READ: Dream Sports and Microsoft Forge Strategic Alliance
